Search
for
Sort by
Research 31–60 of 401
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Cutaneous Reactions to Drugs
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Dermatological Indications: Alopecia Areata
- Androgenetic alopecia – Update 2022
- Immunopharmacological potential of Arctium lappa L. in immune-mediated skin diseases: A critical review of experimental and clinical evidence
- Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence
- Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Fabrication of astaxanthin-loaded electrospun nanofiber-based mucoadhesive patches with water‐insoluble backing for the treatment of oral premalignant lesions
- Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- Head and Neck 3D Bioprinting—A Review on Recent Advancements in Soft Tissue 3D Bioprinting and Medical Applications
- Peculiarities of clinical course and diagnostic of alopecia areata with comorbidity. Clinical observations
- Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case‐series of 64 patients
- Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial
- Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial
- FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery
- FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery
- FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery
- Congenital Hypotrichosis with Hair and Dental Ectodermal Features Responsive to Sublingual Minoxidil
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- 61720 The effect of sublingual minoxidil on androgenetic alopecia in transgender individuals receiving testosterone for gender-affirmation: A 24-week single-centre double-blinded, randomized, placebo-controlled clinical trial
- Sublingual Minoxidil Increases Fibre Diameter in Male Androgenetic Alopecia. - A proxy for Reversal of Hair Follicle Miniaturization.